T and T Mapping in Uremic Cardiomyopathy: An Update

Overview

Journal Card Fail Rev

Date 2022 Feb 3

PMID 35111336

Authors

Luca Arcari

Giovanni Camastra

Federica Ciolina

Massimiliano Danti

Luca Cacciotti

Affiliations

Soon will be listed here.

Abstract

Uremic cardiomyopathy (UC) is the cardiac remodelling that occurs in patients with chronic kidney disease (CKD). It is characterised by a left ventricular (LV) hypertrophy phenotype, diastolic dysfunction and generally preserved LV ejection fraction. UC has a major role mediating the increased rate of cardiovascular events, especially heart failure related, observed in patients with CKD. Recently, the use of T and T mapping techniques on cardiac MRI has expanded the ability to characterise cardiac involvement in CKD. Native T mapping effectively tracks the progression of interstitial fibrosis in UC, whereas T mapping analysis suggests the contribution of myocardial oedema, at least in a subgroup of patients. Both T and T increased values were related to worsening clinical status, myocardial injury and B-type natriuretic peptide release. Studies investigating the prognostic relevance and histology validation of mapping techniques in CKD are awaited.

Citing Articles

Myocardial involvement in end-stage renal disease patients with anemia as assessed by cardiovascular magnetic resonance native T1 mapping: An observational study.

Chen L, Xu R, Xu H, Yang Z, Zhang Y, Li Z Medicine (Baltimore). 2024; 103(46):e39724.

PMID: 39560547 PMC: 11575988. DOI: 10.1097/MD.0000000000039724.

Cardiac Magnetic Resonance Imaging Findings in Patients With Chronic Kidney Disease and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.

Chandramohan D, Rajasekaran R, Konda R, Pujari A, Avula S, Bell M Cureus. 2024; 16(1):e51672.

PMID: 38313918 PMC: 10838180. DOI: 10.7759/cureus.51672.

Chronic kidney disease associated cardiomyopathy: recent advances and future perspectives.

Dobre M, Ahlawat S, Schelling J Curr Opin Nephrol Hypertens. 2024; 33(2):203-211.

PMID: 38193308 PMC: 10872957. DOI: 10.1097/MNH.0000000000000952.

Effect of etelcalcetide versus alfacalcidol on left ventricular function and feature-tracking cardiac magnetic resonance imaging in hemodialysis-a post-hoc analysis of a randomized, controlled trial.

Dorr K, Kammerlander A, Lauriero F, Lorenz M, Marculescu R, Beitzke D J Cardiovasc Magn Reson. 2023; 25(1):62.

PMID: 37932788 PMC: 10626812. DOI: 10.1186/s12968-023-00975-4.

Cardiac Imaging Biomarkers in Chronic Kidney Disease.

Valbuena-Lopez S, Camastra G, Cacciotti L, Nagel E, Puntmann V, Arcari L Biomolecules. 2023; 13(5).

PMID: 37238643 PMC: 10216582. DOI: 10.3390/biom13050773.

References

Hayer M, Radhakrishnan A, Price A, Baig S, Liu B, Ferro C . Early effects of kidney transplantation on the heart - A cardiac magnetic resonance multi-parametric study. Int J Cardiol. 2019; 293:272-277. PMC: 6723623. DOI: 10.1016/j.ijcard.2019.06.007. View

Diao K, Yang Z, Xu H, Liu X, Zhang Q, Shi K . Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis. J Cardiovasc Magn Reson. 2016; 18(1):92. PMC: 5154013. DOI: 10.1186/s12968-016-0313-7. View

Edwards N, Moody W, Chue C, Ferro C, Townend J, Steeds R . Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance. JACC Cardiovasc Imaging. 2014; 7(7):703-14. DOI: 10.1016/j.jcmg.2013.09.025. View

Obremska M, Kaminska D, Krawczyk M, Krajewska M, Kosmala W . Impact of Different Approaches to Kidney Transplant with and without Chronic Hemodialysis on Cardiac Function and Morphology: A Case-Control Study. J Clin Med. 2021; 10(17). PMC: 8432255. DOI: 10.3390/jcm10173913. View

Aoki J, Ikari Y, Nakajima H, Mori M, Sugimoto T, Hatori M . Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int. 2004; 67(1):333-40. DOI: 10.1111/j.1523-1755.2005.00086.x. View

Bull S, White S, Piechnik S, Flett A, Ferreira V, Loudon M . Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart. 2013; 99(13):932-7. PMC: 3686317. DOI: 10.1136/heartjnl-2012-303052. View

Muser D, Nucifora G, Castro S, Enriquez A, Chahal C, Magnani S . Myocardial Substrate Characterization by CMR T Mapping in Patients With NICM and No LGE Undergoing Catheter Ablation of VT. JACC Clin Electrophysiol. 2021; 7(7):831-840. DOI: 10.1016/j.jacep.2020.10.002. View

Puntmann V, Valbuena S, Hinojar R, Petersen S, Greenwood J, Kramer C . Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification. J Cardiovasc Magn Reson. 2018; 20(1):67. PMC: 6147157. DOI: 10.1186/s12968-018-0484-5. View

Arcari L, Hinojar R, Engel J, Freiwald T, Platschek S, Zainal H . Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions - Comparison of uremic, hypertensive and hypertrophic cardiomyopathy. Int J Cardiol. 2020; 306:102-108. DOI: 10.1016/j.ijcard.2020.03.002. View

10.

Edwards N, Moody W, Yuan M, Hayer M, Ferro C, Townend J . Diffuse interstitial fibrosis and myocardial dysfunction in early chronic kidney disease. Am J Cardiol. 2015; 115(9):1311-7. DOI: 10.1016/j.amjcard.2015.02.015. View

11.

Messroghli D, Moon J, Ferreira V, Grosse-Wortmann L, He T, Kellman P . Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular.... J Cardiovasc Magn Reson. 2017; 19(1):75. PMC: 5633041. DOI: 10.1186/s12968-017-0389-8. View

12.

Price A, Hayer M, Vijapurapu R, Fyyaz S, Moody W, Ferro C . Myocardial characterization in pre-dialysis chronic kidney disease: a study of prevalence, patterns and outcomes. BMC Cardiovasc Disord. 2019; 19(1):295. PMC: 6916031. DOI: 10.1186/s12872-019-1256-3. View

13.

Desai K, Laine G, Stewart R, Cox Jr C, Quick C, Allen S . Mechanics of the left ventricular myocardial interstitium: effects of acute and chronic myocardial edema. Am J Physiol Heart Circ Physiol. 2008; 294(6):H2428-34. DOI: 10.1152/ajpheart.00860.2007. View

14.

Buonacera A, Boukhris M, Tomasello S, Campagna A, Cilia C, Tripepi G . Impact of left ventricular remodeling and renal function on 24h-ECG recordings and cardiovascular outcome in elderly hypertensive patients. Eur J Intern Med. 2016; 29:71-7. DOI: 10.1016/j.ejim.2016.01.001. View

15.

von Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer M, Wassmuth R, Greiser A, Schwenke C . Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications. J Cardiovasc Magn Reson. 2013; 15:53. PMC: 3702448. DOI: 10.1186/1532-429X-15-53. View

16.

Hayer M, Radhakrishnan A, Price A, Liu B, Baig S, Weston C . Defining Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac Magnetic Resonance Imaging Study. JACC Cardiovasc Imaging. 2020; 13(11):2357-2367. PMC: 7607516. DOI: 10.1016/j.jcmg.2020.04.021. View

17.

Wang X, Shapiro J . Evolving concepts in the pathogenesis of uraemic cardiomyopathy. Nat Rev Nephrol. 2019; 15(3):159-175. DOI: 10.1038/s41581-018-0101-8. View

18.

Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View

19.

McDiarmid A, Swoboda P, Erhayiem B, Lancaster R, Lyall G, Broadbent D . Athletic Cardiac Adaptation in Males Is a Consequence of Elevated Myocyte Mass. Circ Cardiovasc Imaging. 2016; 9(4):e003579. PMC: 4841180. DOI: 10.1161/CIRCIMAGING.115.003579. View

20.

Sarnak M, Amann K, Bangalore S, Cavalcante J, Charytan D, Craig J . Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019; 74(14):1823-1838. DOI: 10.1016/j.jacc.2019.08.1017. View